Biotechs, Developing Countries Vaccine Manufacturers and Pharma Unite Behind a Proposal to G20 and G7 Offering a Practical Solution for Better Access to Vaccines for Future Pandemics
The proposal intends to ensure that new vaccines developed for future pandemics would reach priority vulnerable populations wherever they live at the same time, and as rapidly as possible.
- The proposal intends to ensure that new vaccines developed for future pandemics would reach priority vulnerable populations wherever they live at the same time, and as rapidly as possible.
- View the full release here: https://www.businesswire.com/news/home/20221023005064/en/
BIO, DCVMN, IFPMA: Biotechs, developing countries vaccine manufacturers and pharma unite behind a proposal to G20 and G7 offering a practical solution for better access to vaccines for futurepandemics (Graphic: Business Wire)
To date nearly 16 billion doses of vaccines for COVID 19 have been produced. - Specifically, the proposal offers to reserve a real-time allocation of vaccines production for vulnerable populations in lower-income countries.
- All their members are fully committed to the goal of COVAX to accelerate development, production, and equitable access to safe, effective, and affordable COVID-19 vaccines.